Gatehouse Bio is developing therapeutics that correct the effects of disease-driving mutations in small RNA genes. We believe there is an RNA code that can treat every disease. Our mission is to find that code and use it to develop effective therapeutics. Our platform is the first to use AI to discover small RNA mutations and design oligonucleotides that crack a disease’s code. Our pipeline and partnerships are focused on developing drugs for therapeutic areas with known heterogeneity such as fibrosis, inflammation and neurodegeneration. With every single code we break, we unlock the potential to improve the lives of many.